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 Xylans are a family of xylose-based polysaccharides naturally present in fruits, 
vegetables, and cereal grains. Resistant to digestion by host enzymes, xylans reach the 
large intestine intact, where they are utilized by members of the gut microbiome. They 
are initially hydrolyzed by primary degraders that utilize extracellular xylanases to cleave 
xylan into smaller oligomers. These xylooligosaccharides (XOS) can then either be 
further hydrolyzed by primary degraders or can cross-feed secondary consumers, 
including Bifidobacterium. While several Bifidobacterium species have metabolic 
systems for XOS, studies have shown these species grow poorly on longer XOS and 
xylan substrates. In this thesis, we assessed the ability of Bifidobacterium 
pseudocatenulatum strains to grow on XOS and xylan. Two distinct phenotypes were 
observed: a xylan+ phenotype, where strains displayed growth on xylan and XOS 
regardless of chain length, and a xylan- phenotype, where strains showed no growth on 
xylan and a preference for shorter XOS fractions. In-silico analysis revealed XOS-active 
gene clusters, with the presence or absence of key genes correlating to observed 
phenotypes. Importantly, only xylan+ strains contained an extracellular GH10 endo-1,4-
beta-xylanase, a key component to primary degradation of xylan. The presence of an 
extracellular xylanase was confirmed by detection of xylan hydrolysates via TLC and 
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HPLC analysis. Furthermore, xylan- strains showed improved growth on xylan when 
combined with a xylan+ strain supernatant, indicating crossfeeding capabilities. These 
results indicate some strains of Bifidobacterium pseudocatenulatum act as primary 
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Preface 
 This thesis is comprised of three chapters. The first chapter is a review of dietary 
fiber utilization in the gut, with an emphasis on role of primary degraders and secondary 
consumers in the consumption of the xylose-based carbohydrate, xylan. Chapter 2 
describes our experimental analysis of the unique role of gut commensal, Bifidobacterium 
pseudocatenulatum in the utilization of xylan and xylan-based oligomers among the 
Bifidobacterium genus. Chapter 3 is a summary of findings and implications of research 
outlined in this thesis, as well as potential future research. 
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 The trillions of microbes that reside in the human gastrointestinal tract depend on 
food constituents that are consumed by the host. Because simple sugars and other small 
molecules are digested and absorbed during transit through the stomach and small 
intestine, only large, complex, or otherwise recalcitrant molecules ultimately reach the 
colon. The ability of various gut microbes to degrade these substrates, including fiber, 
into smaller, more consumable products has a profound influence on the composition of 
the gut microbiome, with important implications for human health. 
 In this review, we provide an overview of the chemistry of this large group of 
complex, non-digestible molecules. We then describe industrial processing of the xylose-
based fiber, xylan, and its conversion into xylooligosaccharides (XOS). Finally, we 
review the biochemical and metabolic steps required for utilization of xylan and XOS by 
primary degraders and secondary consumers in the human gut, with an emphasis on the 
role of Bifidobacterium. 
Dietary Fiber: Definitions and Functional Properties  
Definition. Establishing a clear and consistent definition for dietary fiber has challenged 
scientists for more than 70 years (DeVries, 2004). Dietary fibers are generally described 
as a broad category of plant-derived material resistant to digestion in the human 
gastrointestinal tract. They are typically found in plant cell walls. Historically, different 
national authorities have used varying definitions for what constitutes dietary fiber, where 
some include non-digestible carbohydrates (NDC’s) and others include other plant cell 
wall-associated materials in addition to NDC’s (i.e. lignin, cross-linked polyphenolic 
compounds that interacts with NDC’s) (Jones, 2014; Kay, 1982; Makki et al., 2018). In 
 3 
2009, a standardized definition was described by the Codex Alimentarius Commission. 
They stated that dietary fiber are comprised of carbohydrate polymers of greater than 3 
monomeric units that are not hydrolyzed by endogenous intestinal enzymes from humans 
and included one of the following: 1) intrinsic non-digestible carbohydrates, naturally 
occurring in food as consumed, 2) carbohydrate polymers obtained from food raw 
material via physical, enzymatic or chemical means that offer a physiological benefit, or 
3) synthetic carbohydrates that offer physiological benefit (Lupton, 2009). The U.S. has 
partially adopted this definition, as the Food and Drug Administration (FDA) currently 
defines dietary fiber as ‘non-digestible soluble and insoluble carbohydrates (with 3 or 
more monomeric units), and lignin that are intrinsic and intact in plants; isolated or 
synthetic non-digestible carbohydrates (with 3 or more monomeric units) determined by 
FDA to have physiological effects that are beneficial to human health.’ (21 CFR 
101.9(c)(6)(i)). The latter clause – that a physiological benefit must exist, represents a 
recent, but very important addition to what had been mostly chemically-focused 
definitions. 
 Still, nearly all definitions of dietary fiber include non-digestible carbohydrates 
(NDC), indicating their centrality to the definition of dietary fiber. NDC’s are the dietary 
oligo- and polysaccharides that cannot be degraded by human alimentary enzymes. 
Differences in solubility of these NDC’s play a critical part in the role of these 
carbohydrates in the gastrointestinal tract. Soluble, non-digestible carbohydrates (which 
include pectins, gums, and some hemicelluloses) can be fermented by gut bacteria to 
produce metabolites such as short chain fatty acids (SCFA’s). In contrast, insoluble non-
digestible carbohydrates (i.e., cellulose and lignin) pass through the gut with minimal 
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degradation, and generally do not serve as substrates for gut microbes. However, these 
insoluble NDCs do provide other physiological effects, as discussed below (Capuano et 
al., 2017). Currently (as of 2021), the FDA recognizes a limited number of non-digestible 
carbohydrates (isolated or synthetic) including beta-glucan soluble fiber, psyllium husk, 
cellulose, guar gum, pectin, locust bean gum, and hydroxypropylmethylcellulose. Since 
initial identification of recognized non-digestible carbohydrates, ten additional 
isolated/synthetic fibers are intended to be added to the regulatory definition of dietary 
fiber in the U.S. as of this writing. These proposed fibers include: mixed plant cell wall 
fibers, arabinoxylan, alginate, inulin, high amylose starch (resistant starch 2), 
galactooligosaccharides, polydextrose, resistant maltodextrin/dextrin, cross linked 
phosphorylated resistant starch 4, glucomannan (FDA, 2018). 
Functional properties and physiological effects. The function and effects of dietary 
fiber effect in the gut can vary considerably, depending on their structural properties. 
These structural properties can affect solubility, viscosity, bulking, and fermentability. 
Linear fibers, such as cellulose, are typically insoluble and non-fermentable, but are still a 
key component to normal gut function. The crystalline structure of insoluble fibers 
increase fecal bulk via increased water-holding capacity (water held within the fiber 
matrix). Improved fecal bulking allows for increased stool mass, as well as the alleviation 
of constipation and regularity (Dai et al., 2014).  
 Soluble dietary fibers can be degraded by members of the gut microbiome, a 
diverse microbial community resident to the colon. These microorganisms are known to 
have the genetic machinery to hydrolyze large polymers into smaller molecules. The 
latter can then be transported across cell membranes and metabolized into short chain 
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fatty acids (SCFA) and other end-products. This fermentation activity can be delayed by 
the completeness of the dietary fiber. Intrinsic dietary fibers that contain other cell wall 
components, such as lignins and cell wall-associated proteins, cross-link together, 
blocking enzymatic degradation, thereby slowing microbial fermentation (Moore et al., 
2001). 
Health Properties of Fiber 
 In addition to the chemical and structural properties associated with dietary fiber, 
most current interest is focused on their suggested health benefits. Indeed, as noted 
above, to be labeled as dietary fiber, the FDA now requires that they must provide a 
beneficial physiological effect to human health. Specifically, at least one of the following 
physiological benefits must be demonstrated by the fiber: lowered blood glucose, lowered 
cholesterol levels, lowered blood pressure, increased frequency of bowel movements, 
increased mineral absorption in the intestinal tract, or reduced energy intake (21 CFR 
101.9(c)(6)(i)) (Table 1). Currently, these are the only physiological benefits listed by the 
FDA, although they are considered as “examples” and other potential health benefits 
could still be considered (FDA, 2020). 
The fiber gap While not currently recognized as a beneficial physiological effect by the 
FDA, gut microbiome maintenance is a major factor in overall gut health. Furthermore, 
dietary fiber plays a profound role in regulating the gut microbiome, by acting as the 
major substrate for microbial fermentation. Unfortunately, there is a discrepancy between 
recommended fiber consumption and true fiber consumption in diets. This discrepancy is 
exacerbated by the low fiber, high-fat foods common to the ‘Western’ diet. This so-called 
‘fiber gap’ has been suggested to lead to a depleted or dysbiotic gut microbiome. The 
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latter is not only associated with gastrointestinal disorders such as irritable bowel 
syndrome (IBS) and inflammatory bowel disease (IBD), but also systemic metabolic 
diseases such as obesity, heart disease, and type 2 diabetes (Deehan & Walters, 2016). 
Low-fiber diets lead to a cascade of potentially deleterious health outcomes. First, the 
absence of dietary fiber leads to insufficient substrate reaching the colon. This not only 
causes loss of species reliant upon the substrate, but also reduces production of 
fermentation end-products, such as short chain fatty acids, that reduce colonic pH and 
attenuate inflammation (Sonnenburg et al., 2014). Without this reduction in pH, 
proliferation of acid-labile opportunistic pathogens can occur, further disrupting intestinal 
health. Furthermore, when fibers are absent, some gut microbes shift their focus from 
metabolizing dietary fibers to consuming host-secreted mucus glycoproteins, or mucin 
(Desai et al., 2016). When mucin is degraded, it no longer acts as a protective barrier for 
epithelial cells, allowing for pathogenic invasion and inflammation of the colon (Qu et 
al., 2021).  
Overall, these factors can result in a decrease in microbial diversity and beneficial 
bacteria. To minimize this issue, current scientific opinion has suggested increased 
consumption of dietary fibers, and supplementing other non-digestible oligo- and 
polysaccharides to low-fiber foods, to help restore microbiome diversity (Deehan & 
Walters, 2016). Among the most common fibers consumed by humans are the 
hemicelluloses, of which xylans are among the most abundant. In the next sections, the 
chemistry of the xylans and their derivatives and their effect on microbial fermentation 
and gut health will be reviewed. 
Xylan and XOS Chemistry, Production and Utilization by Microbes  
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Chemistry. Xylans are considered hemicellulosic polysaccharides that are the main 
components of lignocellulosic biomass in the secondary cell walls of plants. They are 
also considered the third most abundant biopolymer on Earth, following cellulose and 
chitin (Beckers et al., 2020).  
 Xylans are comprised of linear polymers of ß-1,4 linked d-xylopyranose units 
typically substituted with acetyl, glucuronic acid, 4-O-methylglucuronic acid (MeGlcA), 
and arabinose residues. The location and degree of substitution to the xylan backbones 
depends on the species and tissue type of the plant source (Rennie et al., 2014). 
 The four major types of xylan found in nature are: linear homoxylan, 
glucuronoxylan, arabinoxylan, and glucuronoarabinoxylan (Bajpai 2014). Linear ß-1,4 
linked homoxylan, while uncommon, can be found in tobacco stalk and esparto grass 
(Fig. 1). Glucuronoxylan is a heteroxylan consisting of the xylan backbone, typically 
acetylated, and substituted with 4-O-methyl-d-glucuronic acid or glucuronic acid (Fig. 1). 
This xylan can be found in hardwoods, soybean hulls, legumes and at low levels in fruits 
and vegetables (Biely et al., 2016, Assor et al., 2013, Broxterman et al., 2018, Martin-
Cabrejas et al., 1995). 
 Arabinoxylan is the major form of dietary xylan (and the only isolated xylan 
recognized as dietary fiber), which consists of the xylan backbone with single or double 
substitutions of α-l-arabinose to the xylose unit. Arabinoxylan is present at high levels in 
rye, barley, wheat, oats, and other cereal grains) and can have different branching 
patterns depending on the source (Fig. 1). As described below, these structural 
differences can lead to different routes of utilization by intestinal bacteria (Rennie et al., 
2014). Finally, glucuronoarabinoxylans are simultaneously substituted by α-l-arabinose 
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and α-d-glucuronic acid and are typically found in perennial plants and dicot primary 
walls. Within this category are galactoglucuronoarabinoxylans, which are 
glucuronoarabinoxylans that also have a terminal ß-l-galactopyranosyl residue present on 
longer side chains to the xylan (Bajpai 2014). (Fig. 1) 
Industrial production of XOS. Xylan backbones can be hydrolyzed into smaller 
oligomer fractions, known as xylooligosaccharides (XOS). The latter are now of 
considerable interest due to their prebiotic potential (Amorim et al., 2019). XOS can have 
a degree of polymerization (DP) ranging between 2 and 20, although most commercial 
XOS products are typically between DP2-6 (Moure et al., 2006, Kim et al., 2014, 
Boonchuay et al., 2016, Joshi et al., 2020). 
XOS can be produced from xylan-containing lignocellulosic material by one of 
several methods (Amorim et al., 2019, Moure et al., 2006). Traditional hydrolysis of 
xylan is performed using a dilute mineral acid, such as dilute sulfuric or hydrochloric 
acid for short periods of time (Samanta et al., 2015). The acid breaks the covalent bond 
between linked xylose units, with the extent of hydrolysis dependent on acid 
concentration and treatment time (Mielenz, 2020; Niju et al., 2020). Autohydrolysis is a 
more recent and environmentally friendly method for xylan hydrolysis, as it only requires 
hot water or steam to induce hydrolysis (Carvalheiro et al., 2016). Enzymatic methods 
rely on xylanases, typically from fungal or bacterial origin, to degrade the xylan 
backbone into smaller XOS fragments. This method is ideal for the production of 
consistent XOS products, as many industry-selected xylanases produce XOS with a 
degree of polymerization between two and six, and rarely produce xylose (Sun et al., 
2015; Liu et al., 2018). However enzymatic processing alone may be inefficient, as xylan 
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in its native form is typically bound to lignins and cellulose, inhibiting xylanase binding 
to xylan (Moreira et al., 2016). Therefore, the most common methods for XOS 
production include an chemical or auto-hydrolytic pretreatment, followed by enzymatic 
hydrolysis and purification, if necessary (Chen et al., 2016, Jang et al., 2021). This allows 
for consistency in the final product, and minimal undesired by-products. (Fig. 2) 
How Microorganisms Degrade and Consume Xylan 
 Xylans are ubiquitous in nature due to their importance in plant cell wall 
structure. Therefore, the ability to break down compact polysaccharides appears to have 
evolved in fungi and bacteria in several ecological biospheres. For example, microbes 
isolated from seawaters (Zhan et al. 2020), alkaline hot springs (Jia et al. 2014), and 
mammalian digestive tracts (Dodd et al. 2010) all have significant xylan degradation 
abilities. In this next section, we will review the microbial enzymatic degradation 
mechanisms for XOS production from xylan, before describing relevant gut 
microorganisms associated with xylan breakdown and consumption in the gut.   
Microbial enzymatic degradation of xylan. The complexity of xylans as shown above 
means that highly specialized enzymes are required for hydrolysis and metabolism by 
microbes. In general these include an extensive array of carbohydrate active enzymes 
(CAZy) for xylan breakdown, as they work synergistically for complete degradation 
(Lombard et al., 2013, Biely et al., 2016). The major enzymes involved in complete xylan 
degradation include both xylanases and accessory enzymes, or enzymes that remove 
decorations on the xylan backbone. (Fig. 3) The most important are the CAZy enzymes 
relevant to xylan degradation would be glycosyl hydrolases (GH), that hydrolyze 
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glycosidic linkages between sugars, and carboxyl esterases (CE), that act to hydrolyze 
ester linkages to carbohydrates (Lombard et al., 2013). 
Accessory enzymes. Accessory enzymes are primarily involved in removal of side 
chains and can include: α-glucuronidases, α-L-arabinofuranosidases, acetylxylan 
esterases, feruloyl esterases (Biely et al., 2016). Glucuronidases (EC 3.2.1.139) belonging 
to GH67 and GH115 work to remove glucuronic acid and MeGlcA linked α-1,2 to the 
xylan backbone in glucuronoxylan. Arabinofuranosidases (EC 3.2.1.37) hydrolyze L-
arabinose units linked α-1,2 or α-1,3 to the xylan backbone. Those active on xylan belong 
to glycosyl hydrolase families GH43, 51,54, and 62 (Malgas et al., 2019, Biely et al., 
2016, Lagaert et al., 2014).  
 Acetylxylan esterases (3.1.1.72) work to remove acetic acid from the acetylated 
xylan backbone(Zhang et al., 2011). Acetylxylan esterases active on xylan can come 
from the carbohydrate esterase (CE) groups: CE1, CE4, CE5, CE6, CE16. For complete 
acetylated xylan degradation, acetylxylan esterases are a necessity to remove the acetic 
acid groups, though alkali treatment also can remove most acetic acid groups (Biely et 
al., 2016). Feruloyl esterases (EC. 3.1.1.73) liberate hydroxycinnamates, such as ferulic 
acid or p-coumaric acid from the xylan backbone, where they can be found in certain 
arabinoxylans (Wong et al., 2013). Substrate specificity for the associated CAZy 
accessory enzymes can be seen in Table 2. 
Xylanases. In addition to accessory enzymes that remove substitutions from the xylan 
backbone, there are also enzymes specialized in cleaving the xylan backbone that are 
considered either exo- acting or endo- acting and can be classified as xylosidases, 
xylanases, or a special family of oligo-xylanases (Biely et al., 2016). Xylosidases achieve 
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exo- action on the non-reducing end of XOS, as they cleave monomer units of xylose, 
and can belong to glycosyl hydrolase families GH3, GH39, GH43, GH52, and GH120 
(Lagaert et al., 2014). Another exo-acting xylanase, GH8 reducing-end-xylose releasing 
exo-oligoxylanase cleaves xylose and xylobiose from the reducing end of xylan 
hydrolysates, with preference for XOS (Valenzuela et al.,2016; Jimenez-Ortega et al., 
2020; Hong et al., 2014).  
 Endo- acting xylan-active enzymes, known as endo- ß-1,4 xylanases, cleave the 
ß-1,4 linkage internally on the xylan backbone to produce XOS of varying chain lengths 
(Biely et al., 2016). These xylanases can belong to a variety of glycosyl hydrolase 
families, including: GH5, GH10, GH11, GH30, and GH98 (Biely et al., 2016). GH5 
xylanases are active only on arabinose-substituted xylans and GH30 xylanases are only 
active on glucuronic acid-substituted xylans (Karlsson et al., 2018; Moreira et al., 2016; 
Biely et al., 2015).  
 Xylanases of highest interest belong to GH10 and GH11, as they do not require 
substitutions to cleave the xylan backbone (Biely et al., 2016; Saka et al., 2016). GH11 
xylanases are low in molecular weight and have a larger substrate binding site, indicating 
the ability to degrade longer xylan chains (Bray et al. 1992). However, due to their large 
binding sites, they require highly unsubstituted xylan as a substrate, relying heavily on 
accessory enzymes to remove chain decorations (Song et al. 2013). Studies indicate 
GH11 xylanases are inefficient on XOS smaller than DP5 and produce fewer soluble end-
products than other xylanase families (Paes et al., 2012; Nieto-Dominguez et al., 2017; 
Ravn et al., 2017).  
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 GH10 xylanases are typically higher in molecular weight with a small substrate 
binding site, active on shorter chains of xylan and XOS (Biely et al. 1997; Kim et al., 
2014). Compared to GH11 xylanases, GH10 xylanases have lower activity on insoluble 
xylan but greater catalytic versatility, meaning they can more easily degrade substituted 
xylan, due to their smaller substrate binding site (Bhardwaj et al., 2019; Nordberg 
Karlsson et al.,2018). Products of GH10 xylanases range in size from xylobiose to 
xylohexaose, though a majority produce xylobiose and xylotriose (Kim et al., 2014; Teo 
et al., 2019; Joshi et al., 2020; Liu et al., 2018; Sun et al., 2015). 
Utilization of Xylan and XOS in the Gut Microbiome 
 Xylan utilization in the human digestive tract relies on several families of gut 
bacteria that are known to use xylans and their hydrolyzed products. In this next section, 
we will describe the relevant gut bacteria associated with xylan and XOS degradation, 
emphasizing those microbes capable of degrading large xylan substrates (primary 
degraders) and those that consume smaller xylan degradation products (secondary 
consumers). 
Primary Degraders. Only a few genera of bacteria are known to directly consume 
xylans. These primary degraders are found mainly in the genera, Bacteroides, Prevotella 
(phyla Bacteroidetes), Roseburia, and Eubacterium (phyla Firmicutes). Mechanisms for 
each differ, as Bacteroidetes are gram-negative bacteria, which means they have two cell 
membranes, with a periplasm in between, while Firmicutes are gram-positive with only 
one cell membrane (Ndeh & Gilbert, 2018). However, in general, all rely on the presence 
of anchored extracellular xylanases for external cleavage of xylans (Ndeh & Gilbert, 
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2018; Hong et al., 2014). Specific mechanisms for how these genera degrade xylans are 
briefly described below. (Fig. 4A) 
Bacteroidetes. The Gram negative Bacteroidetes rely on polysaccharide utilizing loci 
(PULs) for xylan degradation. PULs are gene clusters containing a multitude of 
transporters, regulators, and CAZys relevant to specific glycans (Grondin et al., 2017). 
Among the most well-studied PULs are those involved in starch utilization (SUS), 
typified by gut commensal, Bacteroides thetaiotaomicron (Foley et al., 2016; Dodd et al., 
2010). Collectively, the SUS system relies on the presence of a cell surface-anchored 
extracellular enzyme that hydrolyzes starch and generates oligosaccharides that are 
transported into the periplasm (Dodd et al., 2010; Ndeh & Gilbert, 2018; Tamura et al., 
2021). Monomers are then formed by periplasmic xylanolytic enzymes and are 
transported into the cytoplasm for energy harvesting (Ndeh & Gilbert, 2018; Tamura et 
al., 2021). This is considered a ‘selfish’ capture, as the XOS is immediately transported to 
the periplasm, leaving minimal product extracellular (Briggs et al., 2021). 
 In addition to the SUS system for starch, some species of Bacteroides are also 
xylan primary degraders and xylan and XOS consumers. For example, in Bacteroides 
ovatus two xylan-active PULs were identified, one for simple xylans and another for 
complex glucuronoarabinoxylans. Furthermore, it appears that complex or decorated 
xylans are more closely associated with selfish capture, as the cleaved products are not 
easily assimilated by other microbes (Schwalm III & Groisman, 2017). For example, 
secondary consumers were not capable of growth in co-culture with B. ovatus on 
complex arabinoxylan compared to the simpler arabinoxylan (Rogowski et al., 2015).  
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Firmicutes: Roseburia and Eubacterium. Primary degraders from the Gram positive 
Firmicutes do not have SUS-systems, as they only contain one cell membrane and have 
no periplasm. These bacteria, instead, rely on gram-positive polysaccharide utilizing loci 
(gpPULs). Like PULs from Bacteroidetes, gpPULs also contain genes for membrane-
bound extracellular glycosyl hydrolases and regulators. However, unlike PULs, they lack 
the SUS transport system. They instead rely on ATP-binding cassettes (ABC) 
transporters or PEP-phosphotransferase system (PTS) transporters (Ndeh & Gilbert, 
2018). In this system, the extracellular glycosyl hydrolase cleaves the xylan into XOS 
that is recognized by a substrate binding protein associated with the ATP transport 
system, where it is transported intracellularly for cytoplasmic degradation and 
metabolism. The two major genera from Firmicutes that are associated with primary 
degradation of xylan are Clostridium cluster XIVa organisms, Roseburia and 
Eubacterium (Briggs et al., 2021). Both genera are also associated with production of the 
short-chain fatty acid, butyrate, from carbohydrates (Sheridan et al., 2016).  
Secondary Consumers and XOS Metabolizers. As briefly mentioned above, not all 
primary degradation of xylan leads to selfish capture, especially from simpler xylan. This 
means that some cleaved XOS remains extracellular, free for consumption by whichever 
microbes have the genetic and biochemical wherewithal to metabolize xylan degradation 
products. Accordingly, these secondary consumers have highly specialized substrate 
recognition and transport systems for extracellular XOS. Many belong to the genera 
Lactobacillus and Bifidobacterium (Ndeh & Gilbert, 2018). In addition to these 
secondary consumers, primary degraders are also able, to some extent, to transport 
extracellular XOS as well (Tamura et al., 2021) (Fig 4 B). 
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Bifidobacterium. A wide range of oligosaccharides have been shown to be bifidogenic in 
the gastrointestinal tract. However, XOS is unique among these oligosaccharides as they 
are considered more selective than other commercial prebiotic oligosaccharides, often 
enriching for specific species or even strains (Kaplan and Hutkins, 2000; Rycroft et al., 
2001; Mäkeläinen et al., 2010). Adult-type Bifidobacterium species, particularly B. 
longum ssp. longum and B. adolescentis are known to degrade XOS as they more 
frequently rely on dietary sources of plant fibers compared to infant-associated 
bifidobacteria that can grow on human milk oligosaccharides (Kelly et al., 2021). 
However, strains from B. animalis lactis, B. pseudocatenulatum, B. catenulatum have 
also shown XOS utilization (Gilad et al., 2010; Saito et al., 2020, Palframan et al., 2003). 
 The strain specificity of XOS utilization has been demonstrated in several studies. 
In a survey of twelve strains of Bifidobacterium belonging to B. adolescentis, B. breve, B. 
longum ssp. infantis, B. animalis ssp. lactis, and B. longum ssp. longum, only strains of B. 
animalis ssp. lactis and B. adolescentis were capable of growth on XOS (Mäkeläinen et 
al., 2010). In another study, B. longum ssp. longum, B. adolescentis, and B. 
pseudocatenulatum were isolated from fecal culture enriched with XOS, although only B. 
longum ssp. longum showed persistence when reintroduced to fresh fecal culture 
supplemented with XOS (Kok et a., 2019). In a pangenome and phenotyping analysis, 
only ten of twenty strains of B. longum showed growth on XOS (Arboleya et al., 2018). 
In general, these studies indicate that XOS utilization is both species and strain-
dependent, with longer XOS even more specific.  
 The pathway for XOS metabolism has been recently described in B. 
pseudocatenulatum JCM1200 (Saito et al., 2020). In this strain, three major XOS/AXOS 
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active gene clusters were identified based on increased transcription levels in the 
presence of arabinoxylan hydrolysate substrate. Each cluster contained ABC transport 
systems with specific substrate binding proteins, along with intracellular glycosyl 
hydrolases, associated carboxyl esterases and transcriptional regulators. Each substrate 
binding protein had an affinity for specific decorated XOS/AXOS compounds, meaning 
they most likely only transported specific forms of XOS/AXOS, and all three were 
required for total XOS/AXOS transport (Saito et al., 2020). After the XOS/AXOS is 
transported intracellularly, they are broken down via GH43 xylosidases and 
arabinofuranosidases to their monomer components for metabolism (Saito et al., 2020). A 
similar system for XOS utilization was previously described in B. animalis ssp. lactis 
(Gilad et al., 2010).  
 Although Bifidobacterium is typically only associated with growth on XOS, more 
recent studies suggest that some species can grow on longer xylose-based substrates (Liu 
et al., 2021; Zhu et al., 2021). For xylans containing arabinose or other side chain 
moieties, those components must first be removed from the xylan backbone. This is done 
enzymatically by one GH8 reducing end xylose-releasing exo-oligoxylanase from B. 
adolescentis, that shows low activity in producing xylose from xylan (Arboleya et al., 
2018; Lagaert et al., 2007). However, currently, there are no bifidobacterial strains 
known to grow well on the xylan backbone (Kelly et al., 2021). This corresponds with the 
rarity of GH10 xylanases in bifidobacteria, which are required for xylan degradation 
(Turroni et al., 2018). Still, recent in-silico research has identified a GH10 endo-xylanase 
present in some strains of B. pseudocatenulatum. However, biochemical evidence is 
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needed to confirm if this GH10 xylanase offer confers xylanolytic activity in this species 
(Liu et al., 2021). 
Lactobacillus. Lactobacilli are frequently enriched in vitro after fecal fermentations with 
xylan and XOS (Chen et al., 2020; Hughes et al., 2007; Chen et al., 2015). However, like 
Bifidobacterium, growth on XOS by Lactobacillus is highly strain-dependent. In an 
earlier study with multiple strains from twelve species of Lactobacillus, only strains of 
the species Lactobacillus brevis utilized XOS for growth (Crittenden et al., 2002). More 
recently, strains from L. casei, L. fermentum, L. plantarum, L. zeae also were reported to 
grow on XOS, although high concentrations of XOS were necessary (Ratnadewi et al., 
2020; Li et al., 2015). However, in vitro and in vivo studies suggested that XOS was 
more effective at stimulating growth of Bifidobacteria than Lactobacillus (Finegold et al., 
2014; Li et al., 2015; Chapla et al., 2012). Furthermore, strains of lactobacilli that grow 
on XOS, generally prefer shorter chain length products, such as xylobiose, whereas 
Bifidobacterium strains can utilize varying XOS chain lengths (Moura et al., 2007). 
Transport and metabolism of XOS by lactobacilli is similar to Bifidobacterium, with an 
initial transport of XOS fragments via ABC transporters and internal hydrolysis (Illiev et 
al., 2020). Overall, Lactobacillus appear to be secondary consumers of xylan 
hydrolysates, though they are not as capable as Bifidobacterium in growth in pure culture.  
Conclusions 
 Xylans are a diverse group of xylose-based polysaccharides that can be found in 
the diet. As a source of dietary fiber, these polysaccharides serve as an important 
substrate for microbes in the GI tract that ferment these carbohydrates and produce short 
chain fatty acids and other health-promoting metabolites. The breakdown of these fibers 
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into utilizable substrates by human gut microbes require a diverse array of xylanases and 
accessory enzymes, as described above. Primary degraders, usually members of the 
Bacteroidetes, produce extracellular xylanases that cleave xylan into 
xylooligosaccharides. The resulting XOS fragments from extracellular degradation can 
also be transported and metabolized directly by primary degraders, or they can cross-feed 
secondary consumers, including Bifidobacterium, whose enrichment is associated with 
gastrointestinal health. However, more research is needed to better understand the role 
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Table 1. Isolated and synthetic carbohydrates recognized as dietary fiber by the U.S. 











Table 2. Microbial carbohydrate-active enzymes (CAZy) associated with xylan and XOS 
degradation. 
 











Figure 1. Xylan structure and sources. The structure of xylan varies depending on 
source material. Linear homoxylan is considered the xylan backbone, consisting of a 
linear polymer of ß-1,4 linked d-xylopyranose. Uncommon in nature, it is not found 
in foods, but can be found in tobacco stalk. Arabinoxylan consists of the xylan 
backbone substituted with arabinose units and is the most common dietary xylan and 
is primarily found in cereal grains. Glucuronoxylan consists of the xylan backbone 
substituted with glucuronic acid and 4-0-methyl-glucuonic acid and is also usually 
acetylated. In the diet, glucuronoxylan can be found at low levels in legumes and fruit 
and vegetable skins. The most complex xylan is glucuronoarabinoxylan, consisting of 
both glucuronic acid and arabinose substitutions, and it can be found in cereal grain 







Figure 2. Industrial production of xylooligosaccharides from xylan. Industrial 
production of XOS occurs via one or a combination of three method. Chemical 
hydrolysis uses a dilute acid treatment (i.e., dilute hydrochloric or sulfuric acid), where 
the acid hydrolyzes beta-1,4 glycosidic linkages. Autohydrolysis relies on hydronium 
ions to act as acid catalysts and requires the direct addition of hot water or steam to the 
xylan. This solubilizes the backbone and releases acetyl groups to form acetic acid, which 
can drive additional hydronium production. Enzymatic degradation relies on a simple 
xylanase treatment, such as endo beta-1,4 xylanase to cleave the backbone distinctly, 







Figure 3 Microbial enzymatic degradation of XOS and xylan. Complex xylan 
structures rely on a diverse array of microbial carbohydrate active enzymes (CAZy) to 
either cleave the backbone, as xylanases, or remove substitutions to the backbone, as 
accessory enzymes. Accessory enzymes can include arabinofuranosidases that remove 
the arabinose units; glucuronidases that remove glucuronic acid units; or acetyl esterases 
that remove esterified acetyl groups from the backbone. Xylanases then act on the 
backbone to remove either single xylose units or xylooligosaccharides. Xylose releasing 
xylanases include xylosidase and reducing end exo-oligoxylanases, and XOS releasing 



























































Figure 4. Models for xylan hydrolysate utilization by members of the gut 
microbiome. Xylan utilization in the gut is achieved by primary degraders that cleave 
xylan extracellularly, and secondary consumers, that utilize the resulting XOS. There are 
two phyla associated with primary degradation, Bacteroidetes and Firmicutes. (A) 
Bacteroidetes, as gram-negative bacteria, use polysaccharide utilization loci (PUL) for 
xylan degradation and transport, which include an outer membrane-anchored 
extracellular xylanase, and a SusC/SusD-like transport system to identify and transport 
the resulting XOS into the periplasm for periplasmic XOS degradation. Xylose or 
xylobiose is then transported into the cytoplasm via a major facilitator superfamily 
transporter. While Firmicutes also utilize an anchored extracellular xylanase for primary 
degradation of xylan, as gram-positive bacteria, they only have one membrane, and 
therefore rely on specific substrate binding proteins and ATP-powered transporters and 
permeases. They also hydrolyze small XOS species intracellularly as opposed to 
periplasmically. Secondary consumers belong to the genera Lactobacillus (in Firmicutes) 
and Bifidobacteria (in Actinobacteria). (B) As gram-positive bacteria, they also rely on 
specific substrate binding proteins and ATP-powered transporters, but do not have an 





































 Xylans are a family of xylose-based polysaccharides found in fruits, vegetables, 
and cereal grains. They are resistant to digestion and reach the large intestine intact, 
where they are utilized by members of the gut microbiome. They are initially broken 
down by primary degraders that utilize extracellular xylanases to cleave xylan into 
smaller oligomers. These xylooligosaccharides (XOS), depending on degree of 
polymerization (DP) or linkages, can then either be further hydrolyzed by primary 
degraders or cross feed secondary consumers, including Bifidobacterium. While several 
Bifidobacterium species have metabolic systems for XOS, most grow poorly on long DP 
XOS and xylan substrates. However, we observed some bifidobacteria display growth on 
longer chain XOS, suggesting the XOS phenotype is strain specific. In this study, we 
explored the ability of five Bifidobacterium pseudocatenulatum strains to grow on XOS 
and xylan. Two distinct phenotypes were observed: a xylan+ phenotype, where strains 
grew moderately on xylan and robustly on XOS regardless of chain length, and a xylan- 
phenotype, where strains showed no growth on xylan and moderate growth on XOS, with 
a preference for shorter fractions. In silico analysis found XOS-active clusters in all five 
strains, with the presence or absence of key genes correlating to observed phenotypes. 
Importantly, only xylan+ strains contained a putative extracellular GH10 endo-1,4-beta-
xylanase, a key component for primary degradation of xylan. The presence of an 
extracellular xylanase was confirmed by the appearance of xylan hydrolysis products in 
cell-free supernatants. Extracellular xylanolytic activity was only detected in xylan+ 
strains, as indicated by the production of XOS fragments DP2-6 identified by TLC and 
HPLC. Furthermore, xylan- strains had improved growth on xylan when combined with 
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supernatant from xylan+ strains, indicating cross-feeding capabilities. Strains were then 
grown in stepwise fecal fermentations in the presence of xylan and XOS to assess 
persistence. The xylan+ strain, ED02, persisted on both xylan and XOS in fecal culture, 
while the xylan- strain persisted only on XOS. These results indicate that xylan+ B. 
pseudocatenulatum may have a competitive advantage in the complex environment of the 
gastrointestinal tract, due to their ability to act as primary degraders of xylan through 
extracellular enzymatic degradation.  
Introduction 
 Xylans are considered a class of non-digestible polysaccharides that contain a 
xylose-based backbone with 𝛽-1,4 glycosyl linkages. Linear homoxylans are uncommon 
in foods, rather, they appear in the diet as heteroxylans in the form of arabinoxylans, 
glucuronoxylans, or glucuronoarabinoxylans (Bajpai 2014). These heteroxylans are 
decorated with a variety of other sugars, including arabinose and glucuronic acid, in the 
case of arabinoxylans and glucuronoxylans, respectively. These dietary fibers can be 
found predominantly in cereal grains, although they can also be found at low levels in the 
skins of fruits and vegetables (Rennie et al., 2014, Broxterman et al., 2018). 
 Xylans appear to have evolved as important substrates for fungi and bacteria in a 
variety of ecological biospheres, including seawater, alkaline hot springs, and the 
mammalian digestive tract (Zhan et al., 2020, Jia et al., 2014, Dodd et al., 2010). These 
microbes employ enzymatic machinery that includes a combination of xylanases and 
accessory enzymes that work synergistically to degrade heteroxylan. Xylanases are 
enzymes that cleave 𝛽-1,4 glycosyl linkages between consecutive xylose units in the 
xylan backbone, while accessory enzymes are enzymes that remove decorations from 
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substituted xylan. For substantial xylan degradation, an endo-xylanase is required to 
cleave the interior of the xylan backbone into xylooligomer fractions. These endo-
xylanases, identified via the carbohydrate active enzyme (CAZy) database, typically are 
found in the glycoside hydrolase (GH) families GH5, GH10, GH11, GH30, and GH98 
(Ndeh et al., 2018; Biely et al., 2016). 
 In humans, xylans are resistant to digestion by alimentary enzymes, and reach the 
large intestine intact, where they are subject to fermentation by members of the gut 
microbiome. These fermenters can be categorized as primary degraders and secondary 
consumers, based on their ability to degrade, and consume xylan. Primary degraders are 
capable of direct consumption of xylan; most belong to the phyla Bacteroidetes and 
Firmicutes. For primary degradation of xylan, Bacteroidetes express extracellular 
xylanases that are anchored to the outer membrane and near a SusC/SusD transport 
system. This xylanase degrades the xylan into small XOS species, which are then 
transported into the periplasm by the SusC/SusD receptor, where further dismantling of 
the oligosaccharide occurs. Similarly, primary degradation in Firmicutes also relies on an 
anchored extracellular xylanase, but these gram-positive bacteria utilize substrate binding 
proteins and ATP-requiring transport systems, such as ATP-binding cassettes (ABC) or 
PEP-phosphotransferase system (PTS) transporters to move XOS substrates directly into 
the cytoplasm (Ndeh and Gilbert, 2018).  
 Apart from these primary degraders, other organisms are known to take advantage 
of the xylooligosaccharide products produced by primary degraders via cross-feeding. 
These secondary consumers also gram-positive, like primary degraders in the phylum 
Firmicutes, but do not have the key extracellular xylanolytic activity for direct 
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degradation of xylan. The two major genera of secondary consumers are Lactobacillus 
and Bifidobacterium, which utilize highly specialized substrate recognition and transport 
systems for detection and transport of XOS (Ndeh and Gilbert, 2018). In vitro and in vivo 
studies suggested that XOS was more effective at stimulating growth of Bifidobacteria 
compared to Lactobacillus and is also considered far more selective than other prebiotic 
oligosaccharides studied (Finegold et al., 2014; Li et al., 2015; Chapla et al., 2012; 
Kaplan and Hutkins, 2000; Mäkeläinen et al., 2000). Even within Bifidobacterium, XOS 
utilization is highly specific, with many XOS-capable strains only able to grow on low 
degree of polymerization (DP) XOS fragments. Therefore, growth on longer XOS and 
xylan fragments is a rare trait in Bifidobacterium. In fact, no strain of Bifidobacterium has 
been shown to grow on the insoluble xylan backbone (Kelly et al., 2021). 
  Bifidobacterium pseudocatenulatum, is an adult-type bifidobacteria that is 
clustered in the B. adolescentis phylogenetic group and has been shown to ferment a 
diverse array of carbohydrate sources. (Lugli et al., 2018) Some strains have also been 
reported to have probiotic or health-promoting properties (Biagi et al., 2013; Cano et al., 
2013; Peiroten et al., 2019). This species was of particular interest, as it has been isolated 
from in vitro and in vivo XOS enrichment studies (Kok et al., 2019; Finegold et al., 
2014). Furthermore, genomic analysis of the reference genome B. pseudocatenulatum 
JCM1200 revealed the presence of three arabinoxylan hydrolysate active clusters, whose 
transcription was enhanced during growth on XOS (Saito et al., 2020). This study also 
identified substrate specificity for substrate binding proteins from each cluster, further 
elucidating XOS/AXOS utilization by B. pseudocatenulatum. However, when B. 
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pseudocatenulatum strains were grown on xylan or arabinoxylan, they did not show 
growth (Crittenden et al., 2002; Saito et al., 2020). 
 Recent research in our lab also led to identification of B. pseudocatenulatum 
strains that displayed growth on longer chain XOS and xylan, indicating a potentially 
novel phenotype in Bifidobacterium. In this study, we compared the ability of five 
Bifidobacterium pseudocatenulatum strains to grow on XOS and xylan, in order to 
further clarify the role of B. pseudocatenulatum as a consumer of xylan and xylan 
hydrolysates. We hypothesized that XOS and xylan phenotypes would be associated with 
expression of relevant enzymes as well as gene clusters encoding for these enzymes. 
Materials and Methods 
Isolation and identification of Bifidobacterium isolates. Fifteen putatively unique 
Bifidobacterium isolates from five adult subjects were used in this study. These isolates 
had been previously obtained (Kok et. al, 2019) from in-vitro fecal enrichment 
fermentations with 2% XOS (Prenexus Health, USA) and presumptively identified as B. 
pseudocatenulatum by 16S rRNA sequencing. To confirm species identity, DNA was 
extracted via the QIAamp DNA Mini Kit (Qiagen, USA), and qPCR was performed 
using B. pseudocatenulatum-specific primers (Junick and Blaut, 2012). One isolate from 
each subject was selected as the representative strain for further genomic and functional 
analysis. These strains were renamed as: ED01, ED02, ED03, CR16, and ED05. In 
addition to the Bifidobacterium pseudocatenulatum isolates, eleven Bifidobacterium 
strains from other species were assessed for their ability to utilize xylose-based glycans.  
Growth characteristics of Bifidobacterium strains and isolates. To characterize the 
ability of B. pseudocatenulatum strains to utilize xylose-based glycans, growth studies 
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were performed in modified deMan, Rogosa, and Sharpe media (mMRS) where the 
glucose was replaced with various carbohydrates (Table 1). Strains were first grown on 
MRS plates for 48 hrs., and single colonies were inoculated into MRS broth and 
incubated anaerobically at 37oC for 24 hours in a Sheldon Bactron IV-900 anaerobic 
chamber (Cornelius, OR, USA). Cells were then transferred into MRS, and overnight 
cultures were used to inoculate mMRS containing 0.5% carbohydrate (Table 1). Growth 
experiments were performed in quadruplicate, with a final volume of 200 uL, in 96-well 
microplates. Plates were incubated anaerobically, and optical density measurements (600 
nm) were obtained every 20 minutes using a Tecan Sunrise microplate reader 
(Mannedorf, Switzerland) until stationary phase was reached.  
 To determine growth phenotypes on xylose-based substrates in the 
Bifidobacterium genus, a rapid, high throughput qualitative method was used. Isolates 
were added to mMRS containing the pH indicator bromocresol purple and xylan, LXOS, 
or xylose at 1% concentration. In total, 26 isolates were added to each substrate, in 
triplicate, in 200 uL microwell volumes. Color changes were noted over 48 hours, and a 
change from purple to yellow indicated strain growth on the respective substrate.   
Co-cultures of xylan+ and xylan- strains. To determine if growth on xylan in 
monoculture could predict growth in a more competitive environment, we paired a xylan+ 
strain (ED03) and a xylan- strain (ED05), with the expectation that the xylan+ strain 
Table 1. List of substrates used in study. 
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would out-compete the xylan- strain. This was done by equilibrating the concentrations of 
each strain, 1:1, based on optical density measurements at 600nm (OD600). Then, each 
strain was inoculated, at equal cell densities, into mMRS containing 0.5% substrate. 
Cultures were incubated at 37oC and portions were transferred at a100-fold dilution every 
24 hours for 96 hours. Samples were taken every 24 hours, and DNA was subsequently 
extracted. Quantitative Real Time PCR was performed using strain-specific primers to 
quantify each strain. Results are based on relative abundance of the two strains.  
DNA extraction. Genomic DNA from isolated strains and for pure culture experiments 
was extracted with the QIAamp DNA Mini-Kit using the manufacturer’s protocol for 
gram-positive bacteria (Qiagen, Hilden, Germany). For fecal culture experiments, DNA 
was extracted using BioSprint 96 One-For-All Vet Kits (Qiagen, Hilden, Germany) 
according to manufacturer’s protocol with modifications as described previously (Benson 
et al., 2014). Sample concentrations were quantified using the NanoDrop ND-1000 
Spectrophotometer.  
Whole genome sequencing, assembly, and annotation. Whole genome sequencing of 
the five selected B. pseudocatenulatum strains was performed by the Genomics Core 
Facility at Michigan State. Raw read sequences received from the Genomics Core 
Facility were first checked for read quality using FastQC (Andrews, 2010). The 
sequences were then trimmed using Sickle to remove low quality reads (Del Fabbro et al., 
2013). The reads were assembled into contigs and combined to form scaffolds using 
SPAdes (Bankevich et al., 2012). Scaffolds were reassembled using Mauve with the 
reference genome B. pseudocatenulatum 12 retrieved from NCBI (Darling et al., 2004). 
The assembled genomes were annotated using PROKKA (Seemann, 2014). A summary 
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of features for each strain is shown in Table 5. Additional annotations against the 
carbohydrate active enzyme (CAZy) database were obtained using dbCAN2 to identify 
CAZy clusters (Zhang et al., 2018). The XOS-active CAZy clusters were then compared 
to known XOS/AXOS active clusters identified in B. pseudocatenulatum JCM1200 
(Saito et al., 2020). 
B. pseudocatenulatum pangenome analysis. Pangenome analysis was performed using 
86 B. pseudocatenulatum genomes. The genomes included the 5 strains reported in this 
study, and an 81 additional B. pseudocatenulatum genomes from the Prokaryotic RefSeq 
Genomes database (Li et al., 2021). Pangenomic analyses were performed with anvi-o 
(Delmont & Eren, 2018; Eren et al., 2015). Further annotations were performed using 
dbCAN2 to identify prevalence of XOS active clusters in the B. pseudocatenulatum 
pangenome (Zhang et al., 2018). 
Prevalence of GH10 xylanase in Bifidobacterium. To determine the prevalence of 
GH10 xylanases in Bifidobacterium, 1355 non-redundant Bifidobacterium genomes were 
obtained from the Prokaryotic RefSeq Genomes database from NCBI (Li et al., 2021). 
These genomes were annotated with three CAZy databases, HMMER, DIAMOND, and 
Hotpep, using the dbCAN2 metaserver. (Wheeler &Eddy 2013; Buchfink et al., 2021; 
Busk et al., 2017; Zhang et al., 2018). A genome was considered to contain a GH10 if at 
least two CAZy databases concurred. Species level associations were then assigned. 
Preparation of crude enzymatic supernatants. To determine if extracellular enzymes 
capable of hydrolyzing XOS or xylan were secreted, cell free supernatants were obtained 
from spent XOS culture. Strains were grown anaerobically at 37oC in mMRS 
supplemented with 1% LXOS in 10 mL volumes for 24 hours. Cultures were centrifuged 
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(Eppendorf AG, Hamburg, Germany) at 3100 x g for 10 min. Supernatants were collected 
and re-inoculated at 1% with the same strain for an additional 24 hours in order to 
consume all remaining residual sugars. Cells were centrifuged a second time at 3100 x g 
for 10 min. and filter sterilized with a 0.22 uM filter syringe and divided into two 
aliquots. One aliquot was used directly (see below), and the second was heat-treated at 
95oC for 5 minutes to inactivate enzymes.  
Identification of hydrolysis products. Basal mMRS containing 1% xylan or 1% LXOS 
was supplemented with 20% supernatant that was either heat treated, or not-heat treated.  
This media was incubated for 48 hours at 37oC, with samples were taken at times 0 and 
48 hours. All samples were then heat-treated, as above, after collection to halt further 
enzymatic activity and then stored at -20oC. Identification of hydrolysis products was 
done using high-performance thin-layer chromatography silica gel 60 (Sigma-Aldrich, St. 
Louis, MO). Briefly, 8.5 uL of sample and 5 uL of XOS (15uM) standards DP1-DP6 
(Megazyme, Cork, Ireland) were applied per lane. Plates were developed twice with a 
solvent containing 1-butanol/2-propanol/H2O (3:12:4), dried, sprayed with 0.5% α-
naphthol and 5% H2SO4 in ethanol. 
 For selected samples, analysis of xylan and XOS hydrolysis products was 
performed at the National Renewable Energy Laboratory (NREL) by HPLC. The HPLC 
system, Waters Acquity Ultra Performance LC (Waters Co., Milford, MA), was coupled 
with MS and an ELSD detector. The system ran with a Shodex Sugar SZ5532(Zinc) 
column (Showa Denko K.K., Japan) at 6 x 150 (mm), 6 µm particle size, using a ramped 
mobile phase of acetonitrile and water with .1% formic acid with a flow rate of 0.9 mL 
min-1 and a column temperature of 60 °C. DP fractions were identified via molecular 
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weight and RT matching from standards. Detector responses recorded enzymatic action 
observed by changes in area under the chromatogram curves from baseline to 48 hours. 
Co-culture simulation of B. pseudocatenulatum strains. To assess if cross-feeding was 
occurring between strains, growth curves were performed using the enzymatic 
supernatants described above. Supernatants were added at 20% to fresh media containing 
1% LXOS or xylan. Media was then inoculated with xylan non-fermenting strains and 
incubated for 48 hours. Growth was analyzed by comparing the area under the 
experimental growth curve between growth on supernatant-supplemented media and 
media alone using Growthcurver package in R and comparing the two via a two-sample t 
test (Sprouffske & Wagner, 2016). 
In vitro establishment of B. pseudocatenulatum strains. Fecal samples were obtained 
from five volunteers following UNL Institutional Board Review protocols (IRB 
20160616139). Inclusion criteria included the following: at least 19 years of age, no 
known history of gastrointestinal diseases, no consumption of antibiotics or probiotics in 
the previous 6 months, and no regular consumption of yogurt. The fecal samples were 
then homogenized and stored in phosphate-buffered saline (PBS, pH 7.0), as previously 
described (Kok et al., 2019). 
 Sterile fermentation media was made as described in Yang and Rose (2014) with 
modifications. This included the addition of three substrate treatments at a 0.5% 
concentration: LXOS and xylan, and basal (no added sugars). In addition, there were 
three strain treatments: a xylan grower (ED02), a xylan non-grower (ED01), and no 
added strain (control). The test-of-persistence was performed in stepwise fecal 
fermentations as described previously (Kok et al., 2019; Gomez, unpublished). Briefly, 
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this involved diluting fecal slurries in PBS in a 1:10 ratio, then adding the slurry to the 
selected fermentation media in a 3:6 ratio (vol./vol.) in a total volume of 9.0 mL. Then, B. 
pseudocatenulatum strains ED01 and ED02, grown as previously described, were 
inoculated at 107 cfu/mL into the fecal fermentation media with respective substrate 
treatments. The fermentations were incubated anaerobically at 37oC with subsequent 
dilutions performed in microplate format by transferring 10 uL of spent media into 990 
L fresh fermentation media every 24 hours. This process was repeated three times, with 
samples collected at 0 time, 24, 48, and 72 hours. The DNA was extracted from those 
samples to determine strain persistence by qRT-PCR. Samples were also used for 16S 
rRNA sequencing. 
Strain-specific primer design. Strain-specific primers were designed using RUCS, 
‘rapid identification of PCR primers for unified sequences’ (Thomsen et al., 2017). All 
five isolated B. pseudocatenulatum genomes and two complete B. pseudocatenulatum  
genomes from the NCBI genome database were used to identify unique target sequences. 
Primer specificity was confirmed using NCBI Primer BLAST against the NCBI RefSeq 
representative genome database for bacteria. No primers were accepted that gave hits for 
species present in human fecal samples. Primer annealing temperatures were identified 
using a gradient PCR program and primer specificity was confirmed by performing qPCR 
against all other B. pseudocatenulatum strains isolated. 
Quantification using quantitative real-time PCR. To determine persistence of specific 
strains and total Bifidobacterium in fecal fermentations on different substrates, 
quantitative real-time PCR was performed using strain-specific and genus-specific 
primers (Table 2). Quantitative PCR was performed using these primers with the 
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Mastercycler Realplex2 (Eppendorf AG, Hamburg, Germany). The qPCR master mix 
contained 12.5 L SYBR Green (Thermo Fisher Scientific, MA, USA), 0.5 L forward 
primer, 0.5 L reverse primer, 10.5 L DNA grade water and 1 L of sample, in a total 
volume of 25 L per reaction. The qPCR conditions were as previously described (Junick 
& Blaut,2012). 
 Persistence of strains on respective substrates was statistically analyzed using a 
repeated measure mixed model previously designed in our lab (Gomez, unpublished). 
This model relegates subject as the random effect while prebiotic and time are fixed 
effects. Persistence was measured as the log10 difference in CFU/mL of strains between 
the 24- and 72-hour samples. Analysis was performed using SAS v.9.4 and p-values 








16S rRNA amplicon sequencing and analysis. 16S rRNA sequencing was performed 
following procedures described previously (Kok et al., 2019). The V4 region of the 16S 
rRNA gene was amplified using primers described previously (Caporaso et al., 2010). 
Fecal fermentation samples at the 72-hr time point and the five fecal baselines were 
selected for analysis. Samples were sequenced on an Illumina MiSeq platform with 
Table 2. Bifidobacterium primers used in study. 
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paired-end sequencing of 250 basepairs (bp). A total of 1,292,111 sequences were 
obtained, with a mean of 25,335 sequences per sample (maximum 73,706, minimum 
7,061). 
 Sequence processing was performed using the DADA2 pipeline within QIIME2 
2017.4 (Callahan et al., 2016; Bolyen et al., 2019). Raw sequence data was demultiplexed 
and denoised to remove chimeric sequences and trim forward and reverse reads to 220 bp 
and 160 bp, respectively. Amplicon sequence variants (ASVs) were grouped in each 
sample and taxonomy was assigned using the SILVA 16S database (Quast et al., 2013). 
To further refine output, samples with less than 1,500 reads and ASVs with fewer than 15 
reads were removed. 
 Statistical analysis and visualization of community sequencing data was done in 
QIIME2 2017.4 and RStudio (ver. 4.0.0) (RStudio Team, 2020). Alpha diversity was 
measured via the Shannon Index and compared via a Wilcoxon rank sum test. Beta 
diversity was visualized using a principal coordinate (PCoA) plot of the Jaccard index 
with 95% confidence interval ellipses for the respective treatments. Changes in microbial 
composition from baseline to 72 hours was visualized by Log2 fold change of specific 
ASVs with a significance cutoff of p<0.05. 
Results 
Growth characteristics of Bifidobacterium strains and isolates. While all five 
sequenced B. pseudocatenulatum strains showed growth on glucose and minimal growth 
on basal media (OD < 0.10), differences were observed in the ability to grow on xylan 
and XOS. Two major phenotypes were defined among the five sequenced B. 
pseudocatenulatum strains based on their ability to grow on xylan. Strains ED02 and 
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ED03 were considered xylan-utilizing strains (xylan+) due to their ability to grow 
moderately on xylan (OD > 0.30) and robustly on XOS (OD > 0.45), regardless of chain 
length, as typified by strain ED02 (Fig. 1A, Fig. 1C). Strains unable to grow on xylan 
(xylan-) include ED01, CR16, and ED05. Despite the absence of growth on xylan (OD < 
0.10), these strains had moderate growth on XOS, with a preference for SXOS enriched 
in low DP XOS, as shown for ED01 (Fig. 1B, Fig. 1C). All strains displayed robust 
growth on glucose and no growth on basal media. However, none of the strains indicated 
grew on arabinoxylan (Fig. 1). Strain growth phenotypes are summarized in Figure 1C. 
 In addition to the five characterized strains, a rapid colorimetric qualitative 
growth method was used to screen twenty-one other strains for growth phenotypes on 
xylan, LXOS, and xylose. These included ten additional B. pseudocatenulatum strains 
and eleven strains from other Bifidobacterium species. The B. pseudocatenulatum isolates 
showed similar phenotypes to the previously described xylan+ and xylan- phenotypes 
(Table 3). However, none of the other species of Bifidobacterium grew on xylan, and 
only three of the eleven collection strains grew well on LXOS (Table 4).  
Xylan+ strains do not always outcompete xylan- strains in co-culture. When xylan+ 
and xylan- strains B. pseudocatenulatum strains were grown in co-culture in a 1:1 ratio, 
varying results were observed, depending on substrate. While we hypothesized that 
xylan+ strains would outcompete xylan- strains during growth on XOS and xylan, these 
phenotypes were not always predictive. Thus, while the xylan+ strain ED03 outcompeted 
ED05 on SXOS (Fig. 2A), strain ED05 outcompeted strain ED03 on LXOS. (Fig. 2B). 
Genomic evidence for the presence of GH10 xylanases in Bifidobacterium. In silico 
detection of carbohydrate active gene clusters (CGC’s) in the sequenced B. 
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pseudocatenulatum genomes revealed the presence of three major clusters for XOS 
utilization. These three clusters contain substrate binding proteins, transporters and key 
glycosyl hydrolases. They are distinguished on the basis of substrate binding specificity 
for size and backbone substitution. As hypothesized, the presence or absence of key 
glycosyl hydrolases and transport systems also aligned with the observed phenotypes of 
our strains. All five strains contain genes associated with XOS-active cluster III. This 
cluster includes a substrate binding protein with substrate specificity to short XOS 
products, along with two ABC transporter permeases. In addition, this cluster includes 
two GH43 glycosyl hydrolases associated with monomer (either xylose or arabinose) 
production from XOS. Furthermore, cluster III also contains a transcriptional regulator 
and sugar metabolism genes (Fig. 3, 4). 
 Conversely, strains ED01 and CR16 are missing portions of XOS active cluster I. 
This includes the substrate binding protein, BpAXBP1, with substrate specificity for 
longer XOS. These xylan- strains are also missing the ABC transporter permeases and 
ATP-binding proteins associated with this substrate binding protein. They also are 
missing the GH43 and GH120 glycoside hydrolases with hypothesized xylosidase 
activity (Fig. 3, 4). Cluster I is completely present in strains ED02 and ED03. 
 Xylan+ strains ED02 and ED03 are missing a majority of cluster II, while xylan- 
strains ED01 and CR16 contain the entire cluster. ED02 and ED03 are missing the 
substrate binding protein BpAXBP2, with specificity for arabinose substituted XOS 
fractions. Additionally, these xylan+ strains are also missing associated transport 
permeases, and xylose-releasing glycosyl hydrolases. However, they still contain the 
GH8 reducing end xylose-releasing exo-oligoxylanase associated with cleaving xylose 
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from xylan and XOS. Moreover, the ED02 and ED03 genomes contain an alternate 
cluster II centered around the GH8 xylanase that includes a putative extracellular GH10 
endo-𝛽-1,4- xylanase. Strain ED05 is missing all genes in cluster II (Fig. 3, 4). 
 Pangenome analysis of 86 B. pseudocatenulatum genomes, including the 5 
genomes from this study, indicated the presence of 5620 genes contributing to 1227 core 
genes, 2965 shell genes, and 1428 cloud genes. Among the 86 genomes, 19 contained a 
GH10, including the xylan+ strains, ED02 and ED03 (Fig. 5A). Results indicated that 
some XOS-active gene clusters were more prevalent in the pangenome. For example, 
Cluster III, in its entirety, was present in all strains. Cluster I was the second most 
prevalent, with 64 of 86 genomes containing the complete cluster and all 86 genomes 
containing at least some genes in Cluster I (Fig. 5A). Cluster II was the rarest, as it was 
complete in 33 of the 86 strains, and only 50 of the 86 genomes contained portions of 
Cluster II (Fig. 5A). All strains with an incomplete Cluster II contained the GH8 
reducing-end xylose-releasing exo-oligoxylanase gene. Furthermore, many of these 
partial cluster II genomes were present in the GH10-containing genomes, that contain the 
consecutive GH8 and GH10 xylanases in alternate cluster II found in ED02 and ED03 
(Fig. 5B). 
 Screening for GH10 xylanases in the Bifidobacterium genus using NCBI 
reference sequences revealed that a GH10 xylanase was present in only 29 of 1355 non-
redundant Bifidobacterium genomes, or 2.14% of genomes. Of these twenty-nine strains, 
seventeen were classified as B. pseudocatenulatum, four belonged to Bifidobacterium 
catenulatum sp., three belonged to Bifidobacterium pullorum, and two genomes were 
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identified as Bifidobacterium adolescentis, and singular genomes of B. reuteri, B. 
animalis ssp. lactis, and an unknown Bifidobacterium genome (Fig. 6). 
Hydrolysis products from xylan+ strain supernatants display biochemical evidence 
of xylan+ phenotype and offer cross-feeding opportunity. Both in vitro growth 
experiments and genome analysis indicated that the xylan+ phenotype was dependent on 
an extracellular xylanolytic system. To confirm the presence of an extracellular xylanase, 
cell-free supernatants were collected as a putative source of this enzyme. When LXOS 
media was supplemented with supernatants from all five representative strains, hydrolysis 
products were only observed in media supplemented with ED02 or ED03 supernatant 
(Fig. 7A). This same activity was also observed on xylan, where only the xylan media 
inoculated with the xylan+ supernatant, ED02, resulted in xylan hydrolysis products. 
When the supernatant was heat-treated, no hydrolysis products were formed, indicating 
hydrolysis was due to the presence of extracellular xylanases (Fig. 7B). 
 The presence of an ED02 xylanase and its activity on XOS and xylan were further 
demonstrated by HPLC analysis of hydrolysis products. Results indicated an increase in 
concentration of DP2-4 XOS products and decrease in DP5-13 XOS fragments from 
LXOS, and the production of DP2-DP6 products from xylan (Fig. 8). 
 Finally, cell-free supernatant from ED02 was added to fresh media that was then 
inoculated with the xylan- strains, ED01. Compared to their growth on xylan and XOS 
alone, ED01 was able to grow on XOS and xylan in the presence of the ED02 xylanase 
(Fig. 7C). 
Persistence of strains in fecal culture is consistent with phenotypes in pure culture. 
Persistence of strains during stepwise fecal fermentations containing five different donor 
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sample was generally consistent with their xylan and XOS phenotypes. The xylan+ strain, 
ED02, persisted on XOS in all five subjects and was displaced during fermentation on 
basal media (Fig. 9D, 9F). On xylan, ED02 showed persistence in four subjects and an 
apparent washout for subject A35 (Fig. 9B). However, even including this data point 
from the subject on xylan, no significant difference was observed between XOS and 
xylan for cell count between 24 and 72 hours, while the change in both XOS and xylan 
were significantly different from basal media (Fig. 9H).  
 The xylan- strain, ED01 persisted on XOS for all five subjects and was displaced 
on xylan and basal media for all five subjects (Fig. 9A, 9C, 9E). All treatments were 
significantly different from each other, although both xylan and basal media had more 
than a 2-log reduction, confirming that this xylan- strain could not persist on xylan (Fig. 
9G).    
16S rRNA Analysis. Fecal fermentation samples from the 72-hour time point and from 
the five fecal baseline samples were sequenced via 16S rRNA amplicon sequencing. All 
strain treatment samples, including control treatment, saw a significant decrease in alpha 
diversity by Shannon Index from the fecal baseline with p-values less than 0.001 (Fig. 
11A). Similarly, all substrate treatments were significantly different from the fecal 
baseline in alpha diversity by Shannon Index. Additionally, the XOS treatment was 
significantly less diverse than the basal treatment. (p<0.01) (Fig. 11B). PCoA analysis of 
Jaccard beta-diversity indicated clustering of substrate and strain treatments from the 
fecal baseline. No clustering was seen based on strain treatment, but there was clustering 
seen based on substrate treatment, where control samples were significantly different 
from XOS samples (Fig 11C). 
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 Bifidobacterium was detected in all five fecal baseline samples and was present at 
greater than 5% relative abundance in subjects A33 and A35, initially. Three 
Bifidobacterium-associated ASV’s were detected from the samples, with one associated 
with B. pseudocatenulatum.  
 Basal media, with no added carbohydrates, was used as a substrate control for this 
study, and the relative abundance of Bifidobacterium decreased for ED01, ED02, and 
control treatments. The basal control media was used to identify potential method effects. 
Based on log2fold change analysis comparing basal control fermentation to fecal baseline 
data, a method effect was suggested. Specifically, this method effect was observed as a 
consistent increase in various ‘fast growing’ taxa, including ASV’s from the genera, 
Escherichia-Shigella, Enterococcus, Streptococcus and Fusobacterium (Fig. 12A). Other 
method effects include significant decreases in other fiber-associated bacteria, including 
Roseburia, Akkermansia, and Prevotella (Fig. 12A). 
 In contrast to the decrease in Bifidobacterium during fecal fermentations in the 
absence of carbohydrates, Bifidobacterium was highly enriched with XOS 
supplementation. In the absence of an inoculated strain, but with the addition of XOS, 
subjects A33 and A35, who initially had high bifidobacteria abundance had increases in 
Bifidobacterium relative abundance. Strains ED01 and ED02 also increased in relative 
abundance for all subjects (Fig. 10B). Statistically, this was confirmed as the strain-
associated ASV increases significantly in both ED01 and ED02 supplemented XOS 
media, with a 7.7-fold increase and 9.6-fold increase, respectively (Fig. 12B, 12D).  
 On xylan, relative abundance of Bifidobacterium for all five subjects in both the 
control treatment and ED01 treatment decreased by the 72-hour time point (Fig. 10A). 
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This was statistically significant, as the two non-pseudocatenulatum strain associated 
ASV’s decreased by 21.2-fold and 40.5-fold, respectively (Fig. 12C). In the ED02 
treatment, there was an increase in relative abundance in subjects A31, A33, A34, and 
B39, but a decrease in subject A35. Statistically, based on Log2Fold changes, there was 
no significant change in the B. pseudocatenulatum-associated ASV, while there was a 
significant reduction in one of the baseline-associated ASV’s, with a 21.7-fold reduction 
(Fig. 12E). 
Discussion 
 The importance of xylans as dietary substrates for gut microbes has led 
researchers to identify and characterize strains having the biochemical and genetic means 
to metabolize these carbohydrates. In this study, we propose two major xylan phenotypes 
exist in the species B. pseudocatenulatum. Strains having a xylan+ phenotype, represented 
by strain ED02, were further considered as primary degraders, as illustrated in Fig 13A. 
These strains rely on extracellular degradation of xylan by a GH10 xylanase, forming 
XOS fractions of varying DPs. For B. pseudocatenulatum ED02, xylanase products were 
mainly DP2-DP6, as identified by both TLC and HPLC. This is consistent with the 
activity of GH10 xylanases described previously, that typically produce` DP2-DP6 
products from xylan (Liu et al., 2018; Falck et al., 2013; Boonchuay et al., 2016). Growth 
of ED02 directly on xylan indicated that this strain could also consume these 
oligosaccharides. Genome analysis of the xylan+ strains revealed that they contain Cluster 
I and Cluster III transport systems, whose substrate binding affinities are associated with 
long XOS (> DP4) and short XOS (< DP4), respectively (Saito et al., 2020). Other 
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glycoside hydrolases are also present in the XOS-active clusters that degrade the 
intracellular XOS into xylose, which enters the bifido shunt for subsequent metabolism. 
 In contrast to ED02, which was a primary degrader as well as consumer of xylan, 
other strains, such as ED01, had a xylan- phenotype, but could still grow on XOS. These 
strains were considered as secondary consumers. Thus, in a complex community where 
xylan is hydrolyzed by primary degraders, secondary consumers can still benefit through 
cross-feeding (Fig. 13B). Experimentally, this was demonstrated by the improved growth 
of strain ED01 on LXOS and xylan in the presence of an extracellular xylanase produced 
by ED02. As described above for ED02, xylan- strains likely employ the same XOS 
transport systems, encoded in cluster III. The cluster III system is highly conserved  
in Bifidobacterium, as homologs of this cluster have also been found in B. adolescentis, 
B. catenulatum, and B. longum (Ojima et al., 2022; Liu et al., 2021). 
 We observed that all sequenced strains examined in this study grew better on 
XOS than on xylose. However, this was not entirely surprising, as Bifidobacterium are 
well-known to have adapted to the gut environment, where simple sugars are absent and 
oligosaccharides, including XOS, are more abundant. For example, B. adolescentis was 
reported to have higher specific growth rates on fructooligosaccharides than on their 
constitutive monomer, fructose (Amaretti et al., 2006). Likewise, a strain of 
Bifidobacterium longum subsp. lactis was also shown to grow better on human milk 
oligosaccharides than on glucose (Ward et al., 2006). These findings strongly suggest that 
the ability to grow on oligosaccharides is largely dependent on the presence of relevant 
transporters and associated transport machinery. Moreover, Bifidobacterium are known to 
have a large number of carbohydrate active enzymes, consistent with their ability to adapt 
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to the GI tract, where oligo- and polysaccharide components are more likely to be found 
(Pokusaeva et al, 2011; O’Callaghan & van Sinderen, 2016). 
 Substantial xylan utilization via xylan backbone degradation by Bifidobacterium 
has not been previously reported (Kelly et al., 2021). Growth on arabinoxylan has been 
identified in some strains of B. adolescentis and B. longum, but this growth appears to 
require accessory enzymes that cleave arabinose from the xylan backbone. (Lagaert et al., 
2010; Riviere et al., 2018; Crittenden et al., 2002). In our study, none of the strains 
showed significant growth on arabinoxylan, which is consistent with previous studies of 
B. pseudocatenulatum. (Saito et al., 2020; Crittenden et al., 2002). 
 Interestingly, strains capable of growing on xylan and LXOS neither contained 
the cluster II substrate binding protein, bpAXBP2, nor did they contain the associated 
permeases. However, bpAXBP2 prefers highly substituted AXOS species, as previously 
suggested (Saito et al., 2020). As the XOS and xylan used for our study were not 
substituted with arabinose, this transport system was not necessary for growth on xylan. 
Furthermore, one recent study suggested that the associated substrate binding protein in 
cluster II was the least prevalent, as only 34% of strains contained bpAXBP2, while 
Cluster I SBP and Cluster III SBP were found in 62% and 92% of B. pseudocatenulatum 
strains surveyed. (Ojima et al., 2022). 
 Results from our qualitative, rapid screening of xylan and XOS growth by 
Bifidobacterium strains indicated that no other species grew on xylan. While the strains 
tested were biased towards species in our lab collection, these findings are consistent with 
more expansive screening studies of bifidobacteria (Crociani et al., 1994; Crittenden et 
al., 2002).  
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 Our study is not the first report of a GH10 xylanase in B. pseudocatenulatum. 
Another recent study identified the alternate XOS cluster containing GH8 and GH10 
xylanases present in 9 of 30 strains of B. pseudocatenulatum (Liu et al., 2021). In this 
latter study, which contained a total of 217 strains of Bifidobacterium from six human-
origin species, the GH10 xylanase was found only in B. pseudocatenulatum. This mostly 
agrees with the results of our study, while also confirming the rarity of GH10 xylanases 
in Bifidobacterium, as reported in previous studies (Turroni et al., 2018). However, our 
analyses also identified other GH10 xylan-containing species, including B. catenulatum, 
B. adolescentis and B. pullorum, B. animalis ssp. lactic, and B. reuteri. B. pullorum is 
associated with chickens and B. reuteri is from marmosets, and therefore are not 
considered human-residential strains. In contrast, B. catenulatum and B. adolescentis, 
along with B. pseudocatenulatum, belong to the B. adolescentis phylogenetic group that 
are considered adult-type bifidobacteria (Kato et al., 2016). Thus, their ability to utilize 
dietary fiber is consistent with the presence of a GH10 xylanase (Lugli et al., 2014). Our 
pangenome analysis also revealed similar results to previous findings in B. 
pseudocatenulatum, with the detection and varied presence of three XOS-active gene 
clusters (Saito et al., 2021). However, our study is the first to biochemically define a 
xylan+ phenotype in B. pseudocatenulatum that also correlates with the presence of a 
GH10 xylanase. 
 The ability of B. pseudocatenulatum ED02 to grow on xylan or LXOS might be 
predicted to confer a competitive advantage in mixed cultures or complex environments 
containing XOS as the carbohydrate source. However, when xylan+ and xylan- strains 
were grown in co-culture in LXOS medium, the latter strain was able to out-compete the 
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xylan+ strain. This observation demonstrated that cross-feeding, even between members 
of the same species, had occurred. It is also interesting to speculate that the B. 
pseudocatenulatum group may have evolved as a community, acting in concert to 
degrade and consume xylan-rich substrates and hydrolysis products. This possibility was 
further supported by the in vitro stepwise fermentations. Although ED01 failed to persist 
with xylan as a substrate, this strain persisted on XOS, suggesting that as long as primary 
xylan degraders are present and producing free XOS, XOS consumers could have 
sufficient substrate to grow and persist. 
 Finally, in the in vitro test-of-persistence fermentations, we also observed one of 
the donor samples failed to support growth of the test strain. Specifically, strain ED02 
persisted in four of the donor samples during stepwise fermentation on xylan (based on 
both qPCR and 16S rRNA analyses) but was displaced in sample A35. Thus, A35 would 
be considered a non-responder to this synbiotic pairing, due to potential XOS/xylan -
consuming competitors present in this sample. 
 Collectively, this research contributes to understanding the role of B. 
pseudocatenulatum in the degradation and utilization of xylan and xylan-derived 
oligosaccharides. To our knowledge, this is the first study that has described biochemical 
evidence for a GH10 xylanase for primary degradation of linear xylan by human-origin 
Bifidobacteria. Further in vitro and in vivo studies are needed to examine the role of 
xylan+ Bifidobacterium in the gut on xylan. 
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Figure 1. Growth phenotypes of five B. pseudocatenulatum strains. Growth of 
Bifidobacterium pseudocatenulatum xylan+ strain ED02 (A) and xylan- strain ED01 (B) 
on various xylose-based carbohydrates and growth phenotypes of all five B. 
pseudocatenulatum strains studied (C). Cells were grown in modified deMan, Rogosa, 
and Sharpe (mMRS) media supplemented with 0.5% carbohydrate. Basal media, with no 
added carbohydrate, was used as a negative control and glucose was used as a positive 
control. Growth phenotypes were classified based on change in optical density at 600nm 
(OD600), where (-) indicates no growth with OD600 < 0.1; (+) indicates weak growth 
with 0.1 < OD600 < 0.3; (++) displays moderate growth with (0.3<OD600<0.45); (+++) 

















Table 3. Summary of growth phenotypes of fifteen unique Bifidobacterium 
pseudocatenulatum strains and detection of GH10 xylanase gene via qPCR. 
  Substrate 
qPCR 
Identification 
Isolate Xylan XOS Xylose GH10 
A1-2 - w + N 
A1-3 - w - N 
A1-5 - w - N 
A1-7 - w + N 
ED01 (A1-10) - w - N 
ED02 (A4-10) + + + Y 
ED03 (A5-3) + + - Y 
A7-4 - w + N 
CR16 (A7-5) - w - N 
A7-6 - w + N 
A8-2 + + + Y 
A8-3 - w + N 
A8-4 + + + Y 
A8-7 + + + Y 
ED05 (A8-10) - w - N 
  - = no growth; purple; pH > 6.2 
  w = weak growth; transitional color; 5.2<pH<6.2 
  + = growth; yellow; pH<5.2  
  N = Gene not detected via qPCR 
  Y= Gene detected via qPCR 
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Table 4. Summary of Bifidobacterium collection strain phenotypes on xylose-based 
















- = no growth; purple; pH > 6.2 
w = weak growth; transitional color; 5.2<pH<6.2 







































Figure 2. Co-culture competition results. Relative abundance of xylan+ strain, ED03 
(blue), and xylan- strain, ED05 (red), on XOS of varying chain lengths during co-culture 
competitions. Samples were diluted every 24 hours into fresh media for each time point. 
SXOS is shorter chain XOS, enriched in majority DP<4 and LXOS is long-chain XOS, 
enriched in majority DP>4. A two sample-t test was performed to determine if strain 
relative abundances were significantly different from each other, and significance is 
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Figure 3. Genomic evidence of xylan+ phenotype. The presence or absence of three 
XOS-active gene clusters in reference genome JCM1200 and five representative B. 
pseudocatenulatum strains, as defined previously by Saito et al., 2020 are shown. Gene 
presence is indicated by a filled square, and absence by an open square. Map is color-






























Figure 4. XOS-active gene clusters differ between xylan+ and xylan- phenotypes. 
Genes encoding for XOS-active clusters I, II and III are aligned according to their 








Table 5. Complete genome features of the five Bifidobacterium pseudocatenulatum 














Figure 5. Pangenome results for eighty-six strains of B. pseudocatenulatum. 
Assembled pangenome for eighty-six strains of B. pseudocatenulatum, ordered by 
presence-absence in genomes. (A) The circle phylogram is annotated for GH10 xylanase 
and XOS-active clusters, color-coordinated by their respective gene cluster (cluster I in 
pink, Cluster II in orange, and cluster III in green). Two genes, belonging to CAZy 
families GH8 and GH120, are present in both clusters I and II and are identified in purple 
as Cluster I_II. One gene, a GH43_11 xylosidase, is present in all three clusters and is 
denoted in blue, with the name Cluster I_II_III. Presence of genes in cluster II is further 






















Figure 6. Prevalence of GH10 gene in Bifidobacterium genus. 1355 Bifidobacterium 
genomes obtained from NCBI’s refseq database were screened for GH10 presence using 
dbCAN2, with 29 genomes identified to contain at least one GH10 gene. The species for 
these genomes include B. pseudocatenulatum, B. catenulatum, B. adolescentis, and B. 














Figure 7. Extracellular xylanase activity improves growth of xylan- strains. Thin-
layer chromatography (TLC) results of supernatant inoculated media containing either: 
(A) LXOS (lane 1: LXOS media, lanes 2-6: LXOS media inoculated with respective 
strain supernatant, lane 7: 15mM XOS standards DP1-DP6, Lane 7: Basal media) or (B) 
Xylan (lane 1: xylose, lane 2: 15mM XOS standards DP1-DP6, lane 3: xylan media, lane 
4: xylan media inoculated with ED02 supernatant, lane 5: xylan media inoculated with 
heat-treated ED02 supernatant. Growth curve results from xylan- strains grown in the 
presence or absence of ED02 supernatant-inoculated LXOS and xylan. Growth curves in 
grey indicate growth on substrate alone, while curves in red indicate growth together with 
ED02 supernatant Substrate is indicated by the line pattern, with the dashed line 









Figure 8. High-performance liquid chromatography indicates endo-xylanase activity 
by ED02. Degradation products by ED02 supernatants after 48 h incubation with XOS 
(A) and xylan (B) were separated and quantified by HPLC. In the XOS media, DP2-4 
increased, and DP5-13 decreased. In contrast, on xylan, an increase in DP2-6 
xylooligomers was observed. Trends are indicated by arrows, displaying change in area 


































































Figure 9. Test of persistence of Bifidobacterium pseudocatenulatum strains. Strain 
ED01 on Xylan (A), XOS (C), and basal media (E). Test of persistence of 
Bifidobacterium pseudocatenulatum strain ED02 on xylan (B), XOS (D), and basal media 
(F) in fecal fermentations by qPCR in 5 subjects. Statistical grouping of the average 
change in log10(CFU/mL) between the 72 hour and 24-hour time points by substrate is 
indicated by separate letters for strain ED01 (G) and ED02 (H). Detection limit for each 






















Figure 10. Relative abundance of top twenty bacterial taxa for xylan (A), XOS (B) 
and no substrate (C) treatments from the 72-hour time point of fecal fermentations by 
16S rRNA. Five fecal baseline samples are on far left of each figure, with basal 
treatment, ED01, and ED02 strain treatments adjacent. Each cluster shows subject-






































Figure 11. Alpha and beta-diversity of fecal fermentations. Alpha-diversity by 
Shannon Index metric for strain (A) and substrate (B) effect. Significant differences 
between values indicated by asterisk (* = p<0.05; ** = p<0.01; *** = p<0.001). Principal 
Coordinate Analysis (PCoA) of beta-diversity by Jaccard Index of all 72-hour samples by 
substrate. (C) 95% confidence intervals of substrate treatment are contained within 
ellipses.  
























































Figure 12. Log2Fold change data for fecal fermentations comparing between baseline 
samples and 72-hour samples for: basal control treatment (A), ED01 + XOS treatment 
(B), ED01 + xylan treatment (C), ED02 + XOS treatment (D) and ED02 + xylan 
treatment (E). Each dot represents a unique ASV at the associated genus level, and data 













































Figure 13. Model for xylan and XOS utilization by Bifidobacterium 
pseudocatenulatum. The xylan+ phenotype is implicated as a primary degrader due to the 
secretion of an extracellular xylanase that degrades xylan into smaller oligomers. The 
latter are available for transport by the primary degrader, or they can crossfeed other 
organisms (A). In contrast, strains having a xylan- phenotype may still be secondary 
consumers. Although such strains do not have the extracellular enzymatic machinery or 
transporters to consumer larger XOS and xylan molecules, they instead rely on other 
members of the microbial community to degrade xylans into smaller oligosaccharides 





Chapter 3: Conclusions, Implications and Future Research 
 
 
 The beneficial health effects of dietary fiber are now well established. Moreover, 
lack of fiber consumption can lead to deleterious health outcomes and is associated with 
an increase in metabolic diseases. This so-called ‘fiber gap’ can have a profound impact 
on members of the gut microbiome, leading to a disrupted or dysbiotic microbiota. 
Therefore, understanding the mechanisms by which keystone bacterial species in the gut 
utilize dietary fibers may provide a basis for developing strategies to restore a dysbiotic 
gut microbiome. In this research, we focused on the xylose-based polysaccharide, xylan, 
and its associated hydrolysis products. Current understanding of xylan utilization in the 
gut separates xylan fermenting microbes into two groups: primary degraders and 
secondary consumers. In general, primary degraders utilize extracellular enzymes to 
degrade xylan into utilizable xylooligosaccharides (XOS), that can then be consumed by 
the primary degraders, or those XOS products can cross-feed secondary consumers. In 
general, Bifidobacterium are considered secondary consumers, as many species can grow 
on XOS, but typically do not show growth on longer XOS or xylan itself. In fact, as of 
this year, no Bifidobacterium strain has been shown to grow on the insoluble xylan 
backbone.  
 In the research described in this thesis, we have identified, for the first time, 
strains of the gut commensal, Bifidobacterium pseudocatenulatum, that, have the genetic 
and biochemical basis for growth on longer XOS and xylan substrates. We also identified 
a potential pathway for xylan assimilation in these xylan+ strains. The key findings of this 
research are listed below: 
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• Xylan utilization is a rare phenotype in most bifidobacteria and appears to be a 
strain-specific trait within B. pseudocatenulatum. 
• All B. pseudocatenulatum strains studied displayed growth on XOS and indicated 
stronger growth on XOS than on xylose. 
• The presence or absence of key transporters and glycosyl hydrolases reflect 
observed phenotypes of our strains. 
• Xylan+ B. pseudocatenulatum strains utilize an extracellular xylanase to produce 
XOS products available for transport and metabolism. 
• Xylan- strains saw improved growth XOS products from xylan+ strains, 
implicating potential for cross-feeding. 
• Only the xylan+ strain persisted on xylan in stepwise fecal fermentations, 
indicating this trait may enhance persistence of the strain in a more complex 
environment. 
 
 Overall, the findings of this research indicate that some strains of B. 
pseudocatenulatum may act as primary degraders of xylan, a novel phenotype in this 
important group of gut microbes. Future research should focus on identifying potential 
health properties associated with the xylan+ strains, as their ability to utilize a variety of 
XOS and xylan compounds may indicate potential for synbiotic usage. In addition, 
extending the persistence studies into mouse models could confirm that the xylan and 
XOS phenotypes provide competitive advantages in a complex gastrointestinal 
environment. Therefore, if low-fiber diets are associated with depletion of keystone 
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microbes, then introducing xylan+ B. pseudocatenulatum strains combined with increased 
consumption of xylan fibers could enhance the functionality of the microbiome 
  
 
